Metabolic syndrome and subclinical left ventricular dysfunction

Authors

  • Wilson Cañon Montañez Faculdade de Ciências da Saúde, Universidad de Santander (UDES), Bucaramanga, Colômbia.

DOI:

https://doi.org/10.15448/1980-6108.2016.3.25584

Keywords:

metabolic syndrome X, ventricular function, left, myocardial contraction, echocardiography.

Abstract

Recent studies using both conventional and tissue Doppler echocardiography have gathered evidence of myocardial dysfunction in individuals with metabolic syndrome. Recently, two-dimensional speckle-tracking echocardiography (2D-STE) has become a robust method for the detection of subclinical left ventricular dysfunction through quantitative assessment of myocardial deformation. Some studies suggest that metabolic syndrome is associated with longitudinal deformation of the left ventricle and that global longitudinal strain measured by 2D-STE is impaired in individuals with metabolic syndrome. It may be inferred that the early identification of subclinical left ventricular dysfunction and the determination of the role of the components of metabolic syndrome in impaired myocardial contractility can help elucidate and predict the risk of cardiovascular diseases in this syndrome.

Downloads

Download data is not yet available.

References

Cañon-Montañez W. Strain longitudinal global e síndrome metabólica no ELSA-Brasil: uma análise por ecocardiografia bidimensional speckle-tracking. Porto Alegre. Tese [Doutorado em Epidemiologia] - Universidade Federal do Rio Grande do Sul; 2016. Disponível em: http://hdl.handle.net/10183/139778

Grundy SM. Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab. 2007;92(2):399-404. http://dx.doi.org/10.1210/jc.2006-0513

Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, Rinfret S, Schiffrin EL, Eisenberg MJ. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol. 2010;56(14):1113-32. http://dx.doi.org/10.1016/j.jacc.2010.05.034

Mensah GA, Mokdad AH, Ford E, Narayan KM, Giles WH, Vinicor F, Deedwania PC. Obesity, metabolic syndrome, and type 2 diabetes: emerging epidemics and their cardiovascular implications. Cardiol Clin. 2004;22(4):485-504. http://dx.doi.org/10.1016/j.ccl.2004.06.005

Suzuki T, Katz R, Jenny NS, Zakai NA, LeWinter MM, Barzilay JI, Cushman M. Metabolic syndrome, inflammation, and incident heart failure in the elderly: the cardiovascular health study. Circ Heart Fail. 2008;1(4):242-8. http://dx.doi.org/10.1161/CIRCHEARTFAILURE.108.785485

Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;62(16):e147-239. http://dx.doi.org/10.1016/j.jacc.2013.05.019

Gong HP, Tan HW, Fang NN, Song T, Li SH, Zhong M, Zhang W, Zhang Y. Impaired left ventricular systolic and diastolic function in patients with metabolic syndrome as assessed by strain and strain rate imaging. Diabetes Res Clin Pract. 2009;83(3):300-7. http://dx.doi.org/10.1016/j.diabres.2008.10.018

Shah AM, Solomon SD. Myocardial deformation imaging: current status and future directions. Circulation. 2012;125(2):e244-8. http://dx.doi.org/10.1161/CIRCULATIONAHA.111.086348

Voigt JU, Pedrizzetti G, Lysyansky P, Marwick TH, Houle H, Baumann R, Pedri S, Ito Y, Abe Y, Metz S, Song JH, Hamilton J, Sengupta PP, Kolias TJ, d'Hooge J, Aurigemma GP, Thomas JD, Badano LP. Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging. J Am Soc Echocardiogr. 2015;28(2):183-93. http://dx.doi.org/10.1016/j.echo.2014.11.003

Cañon-Montañez W, Santos ABS, Foppa M. Strain longitudinal global: un parámetro útil para evaluar disfunción ventricular izquierda subclínica en el síndrome metabólico. Rev Colomb Cardiol. 2016;23(2):112-9. http://dx.doi.org/ 10.1016/j.rccar.2015.10.008

Published

2016-10-30

How to Cite

Cañon Montañez, W. (2016). Metabolic syndrome and subclinical left ventricular dysfunction. Scientia Medica, 26(3), ID25584. https://doi.org/10.15448/1980-6108.2016.3.25584